Table 1 Relationship between clinicopathological features and expression of MIER3.

From: MIER3 suppresses colorectal cancer progression by down-regulating Sp1, inhibiting epithelial-mesenchymal transition

Characteristics

n

MIER3 expression

low (%)

high (%)

p value

Gender

Male

88

65

23

0.599

Female

54

42

12

Age (years)

<50

67

52

15

0.555

≥50

75

55

20

Tumor site

Proximal colon

42

32

10

0.925

Distal colon

35

27

8

Rectum

65

48

17

Tumor size (cm in diameter)

<5

48

37

11

0.732

≥5

94

70

24

Tumor differentiation

Good

14

10

4

0.023

Moderate

104

74

30

Poor

24

23

1

Clinical stage

1

15

8

7

0.035

2

53

37

16

3

32

25

7

4

42

37

5

T stage

1~2

23

13

10

0.029

3

98

75

23

4

21

19

2

Lymph node state

Positive

59

50

9

0.029

Negative

83

57

26

Distant metastasis

Positive

42

37

5

0.022

Negative

100

70

30